The scientific platform of MC Sciences is built on the novel discovery of a unique mast cell receptor that controls the entire mast cell activity unlocking the potential for transformative treatments with superior efficacy and a strong safety profile. This scientific breakthrough enables the development of novel therapeutics tailored to address specific unmet needs of several major disease areas in dermatology, respiratory, gastroenterology, fibrotic diseases, chronic inflammation disorders (such MCAS, fibromyalgia, long covid), and neuroinflammation. MC Sciences is now driving the development of these first-in-class superior therapeutics towards patients in several diseases with high and urgent need.
